Introduction

Ultra-sensitive protein quantification is critical for detecting low-abundance proteins in complex biological samples. Traditional proteomics methods often struggle to quantify proteins present at attomole or zeptomole levels, limiting biomarker discovery and precision therapeutics.

Metal-Coded Tagging (MeCAT) is a next-generation quantitative proteomics technology that combines chemical labeling with ICP-MS detection, enabling absolute and multiplexed protein quantification with unprecedented sensitivity.

How MeCAT Works

1. Metal-Coded Tagging
   Proteins or peptides are labeled with isotopically distinct metal tags, which serve as molecular “barcodes.”

• Multiple proteins can be tagged in a single experiment for simultaneous quantification.

2. Separation and Detection
   Tagged proteins are separated using conventional proteomics platforms:

• High-resolution 2D electrophoresis
• SDS-PAGE or chromatography

3. ICP-MS Quantification

• Inductively Coupled Plasma Mass Spectrometry (ICP-MS) detects metal tags with attomol sensitivity.
• This allows absolute quantification, rather than relative measurement, for each protein in a sample.

4. Multiplexed Analysis

• Multiple proteins can be quantified in parallel with high accuracy.
• MeCAT is compatible with downstream mass spectrometry (MALDI-MS, ESI-MS/MS) for protein identification.

Advantages of MeCAT Technology

• Ultra-Sensitive: Detects proteins at extremely low abundance, enabling early biomarker detection.
• Absolute Quantification: Provides precise measurements rather than relative changes.
• Multiplex Capability: Measures multiple proteins in a single experiment.
• Database Independent: Works even for proteins not fully characterized in existing databases.
• Integration with Proteomics Workflows: Compatible with gel-based and gel-free approaches.

Applications

1. Biomarker Discovery
   Detects low-abundance proteins in blood, tissue, or cell lysates that may serve as early indicators of disease.
2. Therapeutic Development
   Measures subtle changes in protein abundance in response to candidate drugs.
3. Systems Biology
   Provides quantitative data for protein network modeling and pathway analysis.
4. Clinical Proteomics
   Supports high-precision studies in oncology, neurology, and immunology by quantifying rare but critical proteins.

Why MeCAT is Innovative

MeCAT represents a paradigm shift in protein quantification. Unlike traditional relative quantification methods, MeCAT enables ultra-sensitive, absolute, and multiplexed protein measurements, bridging the gap between discovery proteomics and precision medicine. Its compatibility with standard proteomics techniques makes it a versatile tool for modern research laboratories.